PMC:7252008 / 2889-3265 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"83","span":{"begin":357,"end":365},"obj":"Disease"},{"id":"84","span":{"begin":366,"end":375},"obj":"Disease"}],"attributes":[{"id":"A83","pred":"tao:has_database_id","subj":"83","obj":"MESH:C000657245"},{"id":"A84","pred":"tao:has_database_id","subj":"84","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Ruscitti et al. [2] prefer the “cytokine storm syndrome” over macrophage activation syndrome (MAS) and indeed we used the “cytokine storm syndrome” terminology within our article but went with “MAS-like” terminology overall As summarized above, we introduced a new concept for MAS classification as gain or loss in immune function that is very relevant for COVID-19 infection."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T19","span":{"begin":32,"end":40},"obj":"Body_part"},{"id":"T20","span":{"begin":62,"end":72},"obj":"Body_part"},{"id":"T21","span":{"begin":123,"end":131},"obj":"Body_part"}],"attributes":[{"id":"A19","pred":"fma_id","subj":"T19","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A20","pred":"fma_id","subj":"T20","obj":"http://purl.org/sig/ont/fma/fma63261"},{"id":"A21","pred":"fma_id","subj":"T21","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"Ruscitti et al. [2] prefer the “cytokine storm syndrome” over macrophage activation syndrome (MAS) and indeed we used the “cytokine storm syndrome” terminology within our article but went with “MAS-like” terminology overall As summarized above, we introduced a new concept for MAS classification as gain or loss in immune function that is very relevant for COVID-19 infection."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T29","span":{"begin":41,"end":55},"obj":"Disease"},{"id":"T30","span":{"begin":62,"end":92},"obj":"Disease"},{"id":"T31","span":{"begin":94,"end":97},"obj":"Disease"},{"id":"T32","span":{"begin":132,"end":146},"obj":"Disease"},{"id":"T33","span":{"begin":194,"end":197},"obj":"Disease"},{"id":"T34","span":{"begin":277,"end":280},"obj":"Disease"},{"id":"T35","span":{"begin":357,"end":365},"obj":"Disease"},{"id":"T36","span":{"begin":366,"end":375},"obj":"Disease"}],"attributes":[{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0008496"},{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"},{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0008496"},{"id":"A33","pred":"mondo_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"},{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"},{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Ruscitti et al. [2] prefer the “cytokine storm syndrome” over macrophage activation syndrome (MAS) and indeed we used the “cytokine storm syndrome” terminology within our article but went with “MAS-like” terminology overall As summarized above, we introduced a new concept for MAS classification as gain or loss in immune function that is very relevant for COVID-19 infection."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T23","span":{"begin":73,"end":83},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T24","span":{"begin":259,"end":260},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Ruscitti et al. [2] prefer the “cytokine storm syndrome” over macrophage activation syndrome (MAS) and indeed we used the “cytokine storm syndrome” terminology within our article but went with “MAS-like” terminology overall As summarized above, we introduced a new concept for MAS classification as gain or loss in immune function that is very relevant for COVID-19 infection."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T12","span":{"begin":62,"end":83},"obj":"http://purl.obolibrary.org/obo/GO_0042116"}],"text":"Ruscitti et al. [2] prefer the “cytokine storm syndrome” over macrophage activation syndrome (MAS) and indeed we used the “cytokine storm syndrome” terminology within our article but went with “MAS-like” terminology overall As summarized above, we introduced a new concept for MAS classification as gain or loss in immune function that is very relevant for COVID-19 infection."}

{"project":"LitCovid-sentences","denotations":[{"id":"T19","span":{"begin":0,"end":376},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Ruscitti et al. [2] prefer the “cytokine storm syndrome” over macrophage activation syndrome (MAS) and indeed we used the “cytokine storm syndrome” terminology within our article but went with “MAS-like” terminology overall As summarized above, we introduced a new concept for MAS classification as gain or loss in immune function that is very relevant for COVID-19 infection."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T3","span":{"begin":32,"end":46},"obj":"Phenotype"},{"id":"T4","span":{"begin":123,"end":137},"obj":"Phenotype"}],"attributes":[{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0033041"},{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":"Ruscitti et al. [2] prefer the “cytokine storm syndrome” over macrophage activation syndrome (MAS) and indeed we used the “cytokine storm syndrome” terminology within our article but went with “MAS-like” terminology overall As summarized above, we introduced a new concept for MAS classification as gain or loss in immune function that is very relevant for COVID-19 infection."}